share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/11/15 06:26

Moomoo AI 已提取核心信息

Conduit Pharmaceuticals announced on November 12, 2024, that its previously issued unaudited financial statements for Q1 and Q2 2024 should no longer be relied upon. The restatement is necessary to correct the classification of deferred commission payable, which was incorrectly categorized as a long-term liability instead of a current liability.The reclassification affects the condensed consolidated balance sheets for the three months ended March 31, 2024, and the three and six months ended June 30, 2024. The company emphasized that this adjustment has no impact on its total liabilities for the affected periods. The company plans to address these changes through amendments to the respective Quarterly Reports on Form 10-Q.
Conduit Pharmaceuticals announced on November 12, 2024, that its previously issued unaudited financial statements for Q1 and Q2 2024 should no longer be relied upon. The restatement is necessary to correct the classification of deferred commission payable, which was incorrectly categorized as a long-term liability instead of a current liability.The reclassification affects the condensed consolidated balance sheets for the three months ended March 31, 2024, and the three and six months ended June 30, 2024. The company emphasized that this adjustment has no impact on its total liabilities for the affected periods. The company plans to address these changes through amendments to the respective Quarterly Reports on Form 10-Q.
Conduit Pharmaceuticals于2024年11月12日宣布,之前发布的2024年第一季度和第二季度未经审计的基本报表不应再被依赖。由于需要更正递延佣金应付的分类,该项应付被错误地归类为长期负债而不是流动负债,因此必须进行重述。重新分类影响了截至2024年3月31日的三个月的简明合并资产负债表,以及截至2024年6月30日的三个月和六个月。公司强调,这项调整对受影响期间的总负债没有影响。公司计划通过对相应的10-Q表季度报告进行修订来解决这些变更。
Conduit Pharmaceuticals于2024年11月12日宣布,之前发布的2024年第一季度和第二季度未经审计的基本报表不应再被依赖。由于需要更正递延佣金应付的分类,该项应付被错误地归类为长期负债而不是流动负债,因此必须进行重述。重新分类影响了截至2024年3月31日的三个月的简明合并资产负债表,以及截至2024年6月30日的三个月和六个月。公司强调,这项调整对受影响期间的总负债没有影响。公司计划通过对相应的10-Q表季度报告进行修订来解决这些变更。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息